亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

安徽聯(lián)創(chuàng)藥物化學有限公司  

醫(yī)藥中間體,醫(yī)藥原料藥

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:葛經(jīng)理
  • 電話:0551-68596228
  • 郵件:sales@lcywhx.com
  • 傳真:0551-68596338
  • QQ:2649585961
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產(chǎn)品 > 特地佐利中間體Ⅱ,380380-64-3
特地佐利中間體Ⅱ,380380-64-3
單價 面議對比
詢價 暫無
發(fā)貨 安徽合肥市付款后3天內
品牌 安徽聯(lián)創(chuàng)
分子式 C7H6BrN5
分子量 240.06
CAS 登錄號 380380-64-3
過期 長期有效
更新 2015-03-02 15:08
 
詳細信息
 基本信息
英文名   5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine
別名   2-(2-Methyl-5-tetrazolyl)-5-bromopyridine
產(chǎn)品名稱   5-溴-2-(2-甲基-2H-四氮唑-5-基)吡啶
分子式   C7H6BrN5
分子量   240.06
CAS 登錄號   380380-64-3
©2025 安徽聯(lián)創(chuàng)藥物化學有限公司 版權所有   技術支持:化工網(wǎng)   訪問量:20782  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |